Story Submitted
AI in clinical trials | Future Advancements of AI and machine learning in clinical trials clinion.com
This article discusses the potential of AI and machine learning in streamlining clinical trials and improving the accuracy of results. From reducing trial time to enhancing data analysis, learn about the exciting future of AI in the clinical trial industry.
Clinion RTSM | Randomisation & trial supply management software | RTSM systems in clinical trials clinion.com
Using RTSM in clinical trials, Clinion RTSM System helps you with efficient patient randomisation and clinical trial supply management. About Clinion Clinion is a life sciences technology company offering innovative software solutions inthe pharmaceutical industry since 2010. Our first product, also called Clinion, is anintegrated eClinical trial platform for small and medium CROs, academic researchorganisations and pharmaceutical companies.
Clinion | eClinical platform | clinical trial software solutions | decentralized clinical trial platform | eclinical system clinion.com
Clinion provides EDC, RTSM, CTMS, eCOA, CSR automation and decentralised trial solutions in an integrated, cloud-based eClinical platform” https://www.clinion.com/
How Clinion Helped Conduct India’s Largest Decentralised Trial with 95% Patient Retention clinion.com
The COVID-19 pandemic has changed how clinical trials will be conducted and managed going forward. Mainly, the urgency and necessity to adopt a virtual platform to efficiently create, deploy, gather verified patient data, and conduct successful trials
Clinion eCOA | Decentralised trials, eConsent and patient diary clinion.com
Clinion eCOA Software is an intuitive and unified eCOA clinical trials solution that allows patients to enter data directly on any mobile device. About ClinionClinion is a life sciences technology company offering innovative software solutions inthe pharmaceutical industry since 2010. Our first product, also called Clinion, is anintegrated eClinical trial platform for small and medium CROs, academic researchorganisations and pharmaceutical companies.